Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,835
Closed -$198K 228
2023
Q1
$198K Hold
6,835
0.01% 151
2022
Q4
$190K Buy
+6,835
New +$260K 0.02% 178

Other funds holding OPTN

683 Capital Management's OPTN Position: Q2 2023 in Review

683 Capital Management sold out of OptiNose (OPTN) in Q2 2023, closing a stake of 6,835 shares — an estimated $198K sold.

683 Capital Management first reported a position in OPTN in Q4 2022 and held it in 2 quarters. The position peaked at $198K in Q1 2023. 61 funds tracked by Wall St. Rank hold OPTN as of Q2 2023.

  • 683 Capital Management reported no remaining OptiNose position as of Q2 2023 after selling out during the quarter.
  • 683 Capital Management sold 6,835 OptiNose shares in Q2 2023, an estimated $198K.
  • 683 Capital Management first reported a position in OptiNose in Q4 2022 and held it in 2 quarters.
  • 683 Capital Management's OptiNose position peaked at $198K in Q1 2023.
  • 61 funds tracked by Wall St. Rank held OptiNose as of Q2 2023.

Based on 683 Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.